Heron Therapeuti Stock Investor Sentiment

HRTX Stock  USD 2.48  0.09  3.77%   
Slightly above 60% of all Heron Therapeuti's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Heron Therapeuti suggests that some traders are interested. Heron Therapeuti's investing sentiment can be driven by a variety of factors including economic data, Heron Therapeuti's earnings reports, geopolitical events, and overall market trends.
  

Heron Therapeuti Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Heron Therapeuti can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a minute ago at simplywall.st         
Heron Therapeutics, Inc.s Shares Bounce 48 percent But Its Business Still Trails The Industry
Simply Wall St News at Macroaxis
18 hours ago at koreatimes.co.kr         
Army partially suspends drone flights after helicopter collision
news
few days ago at gamespot.com         
The Boy And The Heron Steelbook Studio Ghiblis Only 4K Blu-Ray On Sale For Best-Ever Price
news
few days ago at news.google.com         
CM Management LLC Purchases 200,000 Shares of Heron Therapeutics, Inc. - MarketBeat
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Acquisition by Morgan Adam of 17950 shares of Heron Therapeuti subject to Rule 16b-3
Macroaxis News
over a week ago at gurufocus.com         
TANG KEVIN Cs Strategic Acquisition of Aurinia Pharmaceuticals Shares
Gurufocus Stories at Macroaxis
over a week ago at thelincolnianonline.com         
Heron Therapeutics to Release Earnings on Tuesday
news
over two weeks ago at finance.yahoo.com         
Heron Therapeutics, Inc. Just Reported Earnings, And Analysts Cut Their Target Price
Yahoo News
over two weeks ago at thelincolnianonline.com         
Anfield Capital Management LLC Has 182,000 Stock Holdings in Heron Therapeutics, Inc.
news
over two weeks ago at simplywall.st         
Heron Therapeutics shareholders are up 19 percent this past week, but still in the red over the last...
Simply Wall St News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Acquisition by Forbes William P of 371935 shares of Heron Therapeuti at 2.09 subject to Rule 16b-3
news
over two weeks ago at thelincolnianonline.com         
Heron Therapeutics Buy Rating Reaffirmed at Needham Company LLC
news
over two weeks ago at insidermonkey.com         
Heron Therapeutics, Inc. Q4 2024 Earnings Call Transcript
insidermonkey News
over two weeks ago at simplywall.st         
Heron Therapeutics Full Year 2024 Earnings Beats Expectations
Simply Wall St News at Macroaxis
over two weeks ago at gurufocus.com         
Heron Therapeutics Inc Q4 2024 Earnings Call Highlights Record Revenue Growth and ...
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Heron Therapeuti that are available to investors today. That information is available publicly through Heron media outlets and privately through word of mouth or via Heron internal channels. However, regardless of the origin, that massive amount of Heron data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Heron Therapeuti news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Heron Therapeuti relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Heron Therapeuti's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Heron Therapeuti alpha.

Heron Therapeuti Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 13797 shares by Craig Collard of Heron Therapeuti subject to Rule 16b-3
01/17/2025
2
Heron Therapeutics, Inc. is a favorite amongst institutional investors who own 58
01/21/2025
3
Green Heron Partners Announces the Formation of Bison Infrastructure Services and Subsequent Acquisitions of QP Services and Iron Woman Logistics Services
02/24/2025
4
Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates
02/27/2025
5
Heron Therapeutics Inc Q4 2024 Earnings Call Highlights Record Revenue Growth and ...
02/28/2025
6
Acquisition by Morgan Adam of 17950 shares of Heron Therapeuti subject to Rule 16b-3
03/07/2025

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.